Org 31710

Known as: Org-31710 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2016
01219942016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Antiprogestins have been largely utilized in reproductive medicine, yet their repositioning for oncologic use is rapidly emerging… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Progesterone (P4) antagonizes estradiol (E2) in synaptic remodeling in the hippocampus during the rat estrous cycle. To further… (More)
Is this relevant?
Review
2005
Review
2005
ORG 31710 and ORG 33628 were used in studies aiming to control vaginal bleeding in combination with progestagen-only… (More)
Is this relevant?
2005
2005
Progesterone-receptor (PR) stimulation promotes survival in rat and human periovulatory granulosa cells. To investigate the… (More)
Is this relevant?
2001
2001
OBJECTIVE To investigate if progesterone receptor (PR)-mediated effects are involved in regulating the susceptibility to… (More)
Is this relevant?
2000
2000
Org 31710 and Org 33628 are two highly selective progesterone receptor modulators (PRMs) with respect to their anti… (More)
Is this relevant?
2000
2000
Progesterone (P) is one of several local mediators in the ovulatory cascade in the rat. The precise mechanisms of action for P in… (More)
Is this relevant?
1999
1999
To investigate ovulation, an in vitro model with cultured mouse follicles was developed and compared with an in vivo ovulation… (More)
Is this relevant?
1998
1998
The safety and tolerability as well as pharmacokinetics of a new selective antiprogestagen, Org 31710, were studied after oral… (More)
Is this relevant?
1994
1994
Org 31710 and Org 31806 are new antiprogestagens. These compounds were tested for their binding affinity to various steroid… (More)
Is this relevant?